Introduction
loe vera processes some unique and beneficial properties in the field of medicinal plants. In traditional Iranian medicine, Aloe vera was considered as a medicinal plant for the treatment of different diseases [1] . In today's modern medicine, there are no consensus over any disease that can be cured by medicinal plants or their effective therapeutic ingredients. Several studies demonstrated that Aloe vera has antimicrobial, immunomodulatory, and anti-inflammatory activities against pathogens [2, 3] .
Some studies have conducted on the use of mixture of chemical ingredients that makes their statistical interpretation difficult. Limiting spectrum of effects have been studied on immune system that known effects of Aloe A vera extracts often be able to effect on innate immunity insignificantly such as inflammation as compared to adaptive immune responses. However, Aloe vera is considered an immunomodulatory agent in inflammatory conditions [4] . Although, more than 400 species of Aloe vera have been identified so far, Aloe vera (L) Brum. F. is usually utilized in research studies [5] . Also, Tumor Necrosis Factor alpha (TNF-α) and Interleukin-12 (IL-12) cytokines have a prominent role in innate immune responses to eliminate infections. TNF-α production is upregulated when exposed to infections. Also, IL-12 could help produce other cytokines by immune system components, especially macrophages [6] [7] [8] .
Some studies indicate that Aloe vera hydroalcoholic extract has antimicrobial activity on a variety fungal species. In this regard, innate immune responses could eliminate the pathogenic fungal organism but Aloe vera could facilitate and potentiate this performance via stimulating macrophage function as innate immune component [9, 10] . According to previous studies, Aloe vera can increase cell viability in macrophage. On the other hand, people who suffer from immunodeficiency diseases can be infected by opportunistic pathogens such as Candida albicans [4, 11] . Therefore, we evaluated the effect of Aloe vera extract on innate immunity in Balb/C mice model against Candida albicans.
Materials and Methods

Animal preparation
Twenty heads of Balb/c mice were purchased from Pasture institute. Animals in this study were female and healthy and 8-12 weeks old before the experiment. Mice were kept in optimum condition with regard to temperature and humidity. They were randomly divided into five groups of four each. One group is considered as the control group and others were divided into four groups according to the extract dose they received.
Infecting animals with Candida albicans
Amounts of 10 6 -10 7 of Candida albicans counted in RPMI medium, were injected into all mice peritoneum and after a week they were investigated.
Preparation of purified Aloe extract
Aloe vera gel obtained from fresh leaves was mixed with distilled and deionized water with ratio of 1:1 and then centrifuged at 14000 g for 20 min to remove insoluble particles. This soluble was passed through 0.2 µm portions. This study procedure is similar to previous work that performed before.
Determining the extract dose
Normal saline was injected to the control group. Purified Aloe vera extract (100 mg/kg dose) in each injection was considered for the first group. The extract was diluted to 1/2, 1/5 and 1/10 ratio and doses of 50, 20, and 10 mg/kg were prepared for the second to fourth groups, respectively.
Extract administration
About 0.1 mL of normal saline was injected into each mice in the control group for 14 days. Then 0.1 mL of extract with 1/1, 1/2, 1/5 and 1/10 dilution of extract were injected into mice in the first to the fourth experimental groups. Table 1 presents the characteristics of mice groups.
Anesthesia and sampling
Twenty-four hours after the last injection, mice were anesthetized by cotton impregnated with ether. Then the tissues were sampled and kept in the falcon tube under sterile condition.
Macrophages separation
About 5 mL normal saline was injected into each of mice peritoneal cavity and then macrophages were col- lected under sterile condition. The tubes containing macrophages must be maintained at cold temperature to avoid macrophages sticking to tube wall.
Macrophages culture
The obtained suspension from mice peritoneal cavity was centrifuged at 1500 rpm at 8°C for 10 min and supernatant was discarded. For the first washing, 5 mL of cold normal saline was added to sediment macrophages then centrifuged again at 1500 rpm at 8°C for 10 min. Afterward, tube was washed by cold RPMI (Gibco company) and after discarding supernatant, 2 mL cold RPMI containing FBS10% was added to each of mice specific tube and shacked.
Finally, macrophages were counted by neubauer lam and the obtained macrophage cells at 2 mL of culture medium was counted. Then, a volume of 2×10 5 macrophage cells were counted. In order to culture macrophage cells, we used sterile 96-well plate. The plates were placed in an incubator at 37°C with 5% CO 2 . For lymphocytes separation, macrophage cells were sank into the wells bottom and after 1 to 2 hours, the lymphocytes remained stick to the wells. Next, the wells were washed by normal saline to separate lymphocytes from wells. After that, wells volume reached to 200 µL and LPS mitogen was added into three second wells until final concentration reach to 10 µg/mL. The plates were placed in an incubator at 37°C with 5% CO 2 .
NO measurement
Sixteen hours after macrophage cell culture, 50 µL of supernatant were transferred into ELISA plates and culture plate was returned for MTT assay. To measure Nitric Oxide (NO) concentration in supernatant, 50 µL of 1% sulfonyl amide solution was added into 5% acid phosphoric and immediately 50 µL of 1% NEDA solution was added into 5% acid phosphoric. After 5 minutes, the optical absorption was measured by ELISA reader at 492 nm wavelength.
MTT assay
After incubating for 24 h, upper supernatant was collected to measure Tumor Necrosis Factor alpha (TNF-α) cytokine. Then, RPMI with 10% FBS in the same volume of supernatant was immediately added to wells and 20 µL of MTT solution were added into each well, then the plates were incubated for 4 h. Finally, 100 µL of isopropranolol were dispensed into each well and optical density was read by ELISA reader at 492 nm wavelength.
NBT measurement
Upper supernatant of the plates was collected and 50% RPMI with 10% FBS plus 50% sterile NBT solution were added into each well to measure NBT. After incubating for 1 h, upper supernatant was discarded and bottom cells were solved by pyridine and optical density was read at 493 nm wavelength.
Cytokine measurement
Cytokine measurement was performed by ELISA assay based on manufacturers' instruction. At first, the supernatant was collected from infected mice with Candida albicans which were under Aloe vera treatment. To measure TNF-α (Biosource company), first the antibody with certain concentration was coated on the bottom of 96-wells plate and kept them in the refrigerator for 18 h. After that, blocking level was performed by BSA solution. Next, the fluid inside the wells was moved out then the sample and standard were dispensed into each determined well. The plates were incubated. After washing three times, the second antibody was added and the plates were incubated at room temperature. After washing, enzyme, substrate, and stopping solution were added into wells consecutively at regular intervals. Optical density was read by ELISA reader (ICNflow Company). Interlukin-12 (IL-12) cytokine level was measured by ELISA as in TNF-α cytokine measurement.
Results
Macrophage vital activity
Different doses of Aloe vera extract significantly decreased macrophage vital activity without mitogen compared to the control group in model mice infected with Candida albicans (P<0.025). However, there was significant increase in macrophage vital activity in doses of 20, 50 and 100 mg/kg in the presence of mitogen (P<0.034) (Figure 1) . Also, the effect of Aloe vera extract on macrophage vital activity in mice infected with Candida albicans demonstrated a significant increase in doses of 20, 50 and 100 mg/kg in comparison to the control group (P<0.041) (Figure 2 ).
NO production
Results of Aloe vera extract effect on NO production without mitogen showed significant decrease in NO production at treated doses of 10, 20 and 50 mg/kg of Aloe vera as compared to the control group (P<0.001) ( Figure  3) . Also, there was significant decrease in NO produc-tion at all doses as compared to control group with mitogen stimulation (P<0.0001) (Figure 4 ).
Cytokine measurement
Results of TNF-α assay with mitogen showed a significant increase in TNF-α in 20 mg/kg treated dose of Aloe vera as compared to the control group (P<0.013) ( Figure  5 ). Also, results of IL-12 with mitogen indicate significant increase in IL-12 at 10 mg/kg dose as compared to the control group (P<0.001). But in treated dose of 100 mg/kg of Aloe vera, significant decrease in IL-12 was observed compared to the control group (P<0.01). Moreover, results of IL-12 without mitogen showed significant decrease in groups which were received Aloe vera extract in doses of 50 or 100 mg/kg (P<0.001).
Discussion
Candida albicans is one of the most frequent pathogens among Candida spp, causing sever candidiasis in susceptible patients, like those who undergone transplant, have malignancy, or hospitalized in ICU units. There are several approaches to treat or prevent Candida albicans. Recent efforts have focused on immunotherapy in Candida albicans infection [12] . An increase in macrophage cell viability against Candida albicans has been reported after Aloe vera consumption [4, 13, 14] . Furthermore, TNF-α can remove fungal infections and IL-12 secreted by macrophages could help secrete IFN-γ as cellular immunity against fungal infections [6] [7] [8] .
In the present study, we tried to determine the effect of Aloe vera herbal extract on innate immunity. In this regard, TNF-α and IL-12 cytokine secretion were measured as index of innate immunity and inflammatory responses. Results demonstrated that macrophage vital activity elevated after stimulation with mitogen. But, NO production decreased significantly with or without mitogen. In this regard, Karace et al. reported that carbohydrate derived from Aloe vera could induce NO production from macrophage [15] . In addition, effect of isolated fractions on TNF-α and IL-12 secretion by macrophages against Candida albicans was evaluated.
The results showed that TNF-α and IL-12 cytokine increased after stimulating by mitogen in certain doses. The optimum effect of Aloe vera extract on TNF-α secretion by macrophage were obtained at 20 mg/kg dose. Also, the optimum effect in IL-12 secretion was 10 mg/kg with mitogen stimulating but in doses of 50 and 100 mg/kg were the optimum points to produce IL-12 cytokine from macrophage. [16] . In another study, Habeeb et al. reported that Aloe vera can suppress TNF-α production and modulate inflammatory responses in bacterial infection [17] . Similarly, our results revealed that Aloe vera could promote innate immune responses through increased production of IL-12 and TNF-α cytokines. Macrophage activity was potentiated by these cytokines and could eliminate fungal infections such as Candida albicans [18, 19] .
Actually, the increased production of TNF-α cytokines is associated with better performance of innate immunity, especially macrophage cells. In addition, IL-12 is able to activate antimicrobial peptides such as cathelicidins, promote autophagy, and inhibit intracellular infectious disease [19, 20] . IL-12 cytokine also leads to differentiate TH1 cells [21] . Taken together, Aloe vera extract can stimulate innate and adaptive immunity to respond the infection with more efficiency. Our findings revealed that Aloe vera has significant effect in eliminating fungal infections via elevated secretion of key cytokines such as TNF-α and IL-12 in vivo study model. Further studies are necessary to evaluate which Aloe vera ingredient(s) has the ability to stimulate immune responses against fungal infectious diseases.
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